CRLVSSXTC• 6 Months (Normalized)
CRL vs SXTC (Charles River Laboratories International Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Apr 9 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CRL Performance $304.96
+73.72%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
SXTC Performance $1.25
-99.25%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin CRL LEADS
+172.97 pts
CRL outperforming by 172.97 percentage points
CRLSXTC
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CRL SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | CRL Price | CRL Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $304.96 | +73.72% | $1.25 | -99.25% | +172.97% |
| Oct 05, 2026 | $310.77 | +77.03% | $2.08 | -98.74% | +175.77% |
| Oct 02, 2026 | $290.19 | +65.30% | $2.41 | -98.54% | +163.84% |
| Oct 01, 2026 | $286.83 | +63.39% | $2.96 | -98.21% | +161.60% |
| Sep 30, 2026 | $295.01 | +68.05% | $3.01 | -98.18% | +166.23% |
| Sep 29, 2026 | $295.96 | +68.59% | $2.81 | -98.30% | +166.89% |
| Sep 28, 2026 | $294.59 | +67.81% | $2.52 | -98.48% | +166.29% |
| Sep 25, 2026 | $292.84 | +66.81% | $- | - | |
| Sep 23, 2026 | $277.33 | +57.98% | $2.51 | -98.48% | +156.46% |
| Sep 22, 2026 | $285.11 | +62.41% | $- | - | |
| Sep 21, 2026 | $279.01 | +58.93% | $2.38 | -98.56% | +157.49% |
| Sep 18, 2026 | $278.06 | +58.39% | $2.40 | -98.55% | +156.94% |
| Sep 17, 2026 | $281.67 | +60.45% | $2.44 | -98.53% | +158.98% |
| Sep 16, 2026 | $273.41 | +55.74% | $2.19 | -98.68% | +154.42% |
| Sep 15, 2026 | $272.88 | +55.44% | $2.36 | -98.57% | +154.01% |
Page 1 of 9